David James Pinato
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 124
- Hepatocellular Carcinoma Treatment and Prognosis 116
- Oncology 167
- Cancer Immunotherapy and Biomarkers 82
- COVID-19 and healthcare impacts 21
- Inflammatory Biomarkers in Disease Prognosis 20
- Colorectal Cancer Treatments and Studies 17
- Pancreatic and Hepatic Oncology Research 17
- Co-authors
- Rohini Sharma (60 shared papers)Francesco Angelo Mauri (23 shared papers)Mathias Heikenwalder (2 shared papers)Josep Maria Llovet (2 shared papers)Richard S. Finn (4 shared papers)Vincenzo Mazzaferro (1 shared paper)Florian Castet (1 shared paper)Andrew Xiuxuan Zhu (1 shared paper)
- Journals
- Journal of Hepatology (31 papers)Journal for ImmunoTherapy of Cancer (21 papers)Annals of Oncology (17 papers)European Journal of Cancer (14 papers)JHEP Reports (12 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
David James Pinato
341 papers receiving 14.1k citations
David James Pinato's Hit Papers
Peers
Comparison fields: 5 of 129
- Hepatology 4.1k
- Oncology 5.1k
- Cancer Research 1.4k
- Immunology 1.7k
- Epidemiology 1.8k
Countries citing papers authored by David James Pinato
This map shows the geographic impact of David James Pinato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David James Pinato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David James Pinato more than expected).
Fields of papers citing papers by David James Pinato
This network shows the impact of papers produced by David James Pinato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David James Pinato. The network helps show where David James Pinato may publish in the future.
Co-authors
The 25 scholars most cited alongside David James Pinato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 364 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunotherapies for hepatocellular carcinoma Hit paper breakdown → | 2021 | 1335 |
| 2 | NASH limits anti-tumour surveillance in immunotherapy-treated HCC Hit paper breakdown → | 2021 | 1006 |
| 3 | Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer Hit paper breakdown → | 2019 | 492 |
| 4 | 2012 | 369 | |
| 5 | 2016 | 326 | |
| 6 | 2017 | 266 | |
| 7 | Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score Hit paper breakdown → | 2021 | 226 |
| 8 | 2020 | 212 | |
| 9 | 2020 | 201 | |
| 10 | Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study Hit paper breakdown → | 2022 | 186 |
| 11 | 2020 | 170 | |
| 12 | 2012 | 159 | |
| 13 | 2019 | 159 | |
| 14 | 2021 | 159 | |
| 15 | 2022 | 156 | |
| 16 | 2021 | 153 | |
| 17 | 2020 | 150 | |
| 18 | 2020 | 144 | |
| 19 | Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept Hit paper breakdown → | 2023 | 142 |
| 20 | 2014 | 139 |
About David James Pinato
David James Pinato is a scholar working on Hepatology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 364 papers that have together received 14.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (116 papers), Cancer Immunotherapy and Biomarkers (82 papers), Liver Disease Diagnosis and Treatment (24 papers), COVID-19 and healthcare impacts (21 papers), Inflammatory Biomarkers in Disease Prognosis (20 papers), Colorectal Cancer Treatments and Studies (17 papers), Pancreatic and Hepatic Oncology Research (17 papers) and Cancer Genomics and Diagnostics (16 papers). The work is most often cited by research in Hepatology (4.1k citations), Oncology (5.1k citations), Cancer Research (1.4k citations), Immunology (1.7k citations) and Epidemiology (1.8k citations). David James Pinato has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Rohini Sharma, Francesco Angelo Mauri, Mathias Heikenwalder, Josep Maria Llovet, Richard S. Finn, Vincenzo Mazzaferro, Florian Castet, Andrew Xiuxuan Zhu, Eli Pikarsky and Mala K. Maini. Their work appears in journals such as Journal of Hepatology, Journal for ImmunoTherapy of Cancer, Annals of Oncology, European Journal of Cancer and JHEP Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.